International metastatic renal cell carcinoma database consortium classification and regression tree analysis to characterize objective response rates to first line in metastatic renal cell carcinoma - Top-Institutions - MDSpire

International metastatic renal cell carcinoma database consortium classification and regression tree analysis to characterize objective response rates to first line in metastatic renal cell carcinoma

  • By

  • Martin Zarba

  • Dylan O’Sullivan

  • David Maj

  • Winson Y. Cheung

  • Lisa Ludwig

  • Connor Wells

  • Evan Ferrier

  • Razane El Hajj Chehade

  • Frede Donskov

  • Marc Eid

  • Sumanta Kumar Pal

  • Benoit Beuselinck

  • Rana R. McKay

  • Lori Wood

  • Jae Lyun Lee

  • Cristina Suárez

  • Kosuke Takemura

  • Ignacio Duran

  • Toni K. Choueiri

  • Daniel YC Heng

  • May 4, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Arthur J.E. Child Comprehensive Cancer Centre, University of Calgary
    Arthur J.E. Child Comprehensive Cancer Centre, University of Calgary

    Calgary, Alberta

    Key Differentiators

    • Oncology

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology

  • #4

    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

    Baltimore, MD

    Key Differentiators

    • Oncology

  • #5

    Cleveland Clinic Taussig Cancer Institute
    Cleveland Clinic Taussig Cancer Institute

    Cleveland, OH

    Key Differentiators

    • Oncology

Original Source(s)

International metastatic renal cell carcinoma database consortium classification and regression tree analysis to characterize objective response rates to first line in metastatic renal cell carcinoma

  • by Martin Zarba, Dylan O’Sullivan, David Maj, Winson Y. Cheung, Lisa Ludwig, Connor Wells, Evan Ferrier, Razane El Hajj Chehade, Frede Donskov, Marc Eid, Sumanta Kumar Pal, Benoit Beuselinck, Rana R. McKay, Lori Wood, Jae Lyun Lee, Cristina Suárez, Kosuke Takemura, Ignacio Duran, Toni K. Choueiri, Daniel YC Heng

  • May 4, 2026

Related Content

PD-1 inhibitor combined with chemoradiotherapy in two cases of ovarian cancer brain metastases: a case report

Synthetic short RNA in cancer

Financial Hardship and Nonadherence to Lifestyle and Surveillance in Childhood Cancer Survivors